Role of lysophosphatidylcholine in eosinophil infiltration and resistance in airways

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 3, 2004, Pages 179-184

  Nishiyama, Osamu ^a   Kume, Hiroaki ^a   Kondo, Masashi ^a   Ito, Yasushi ^a   Ito, Masafumi ^b   Yamaki, Kenichi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Airway resistance; Bronchial asthma; Eosinophil recruitment; Lysophosphatidylcholine; Phospholipase A2

Indexed keywords

DEXAMETHASONE; LYSOPHOSPHATIDYLCHOLINE;

AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHIOLE; BRONCHUS; CELL INFILTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EOSINOPHIL; EXPOSURE; GUINEA PIG; HISTOLOGY; INHALATION; LUNG LAVAGE; LYMPHOCYTE; MALE; MEDICAL RECORD; NONHUMAN; PROTEIN FUNCTION; TIME;

AIRWAY RESISTANCE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; EOSINOPHILS; GUINEA PIGS; LUNG; LYMPHOCYTES; LYSOPHOSPHATIDYLCHOLINES; MALE; NEUTROPHILS; RATS; TIME FACTORS;

EID: 1542512185     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.03973.x     Document Type: Article

References (27)

1. Niewoehner DE, Rice K, Sinha AA, Wangensteen D. Injurious effects of lisophosphatidylcholine on barrier properties of alveolar epithelium. J. Appl. Physiol. 1987; 63: 1979-86.
2. Amirkhanian JD, Taeusch HW. Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents. Biochim. Biophys. Acta 1993; 1165: 321-6.
3. Lindahl M, Hede AR, Tagesson C. Lisophosphatidylcholine increases airway and capillary permeability in the isolated perfused rat lung. Exp. Lung Res. 1986; 11: 1-12.
4. Martin TW, Lagunoff D. Interactions of lysophospholipids and mast cells. Nature 1979; 279: 250-2.
5. Marquardt DL, Walker LL. Lysophosphatidylcholine induces mast cell secretion and protein kinase C activation. J. Allergy Clin. Immunol. 1991; 88: 721-30.
6. Nath P, Joshi AP, Agrawal KP. Biochemical correlates of airway hyperreactivity in guinea pigs: Role of lysophosphatidyl choline. J. Allergy Clin. Immunol. 1983; 72: 351-8.
7. 2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am. J. Respir. Crit. Care Med. 1997; 155: 421-5.
8. Chilton FH, Averill FJ, Hubbard WC, Fonteh AN, Triggiani M, Liu MC. Antigen-induced generation of lyso-phospholipids in human airways. J. Exp. Med. 1996; 183: 2235-45.
9. 2+ sensitization in tracheal smooth muscle. Am. J. Respir. Cell. Mol. Biol. 2001; 25: 291-8.
10. Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 1992; 90: 1138-44.
11. Scalia R, Murohara T, Campbell B, Kaji A, Lefer AM. Lysophosphatidylcholine stimulates leukocyte rolling and adherence in rat mesenteric microvasculature. Am. J. Physiol. 1997; 272: H2584-90.
12. Nishi E, Kume N, Ueno YH, Ochi HH, Moriwaki H, Kita T. Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocytes. Circ. Res. 1998; 83: 508-15.
13. Kume N, Gimbrone Jr MA. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 1994; 93: 907-11.
14. + channel activator, on airway smooth muscle contraction and systemic blood pressure. Clin. Exp. Allergy 1997; 27: 705-13.
15. Aoki S, Tsukagoshi H, Kurosawa M. Changes in respiratory resistance and dynamic compliance induced by histamine in the guinea pig. Jpn. J. Thorac. Dis. 1991; 29: 1239-46.
16. Ceyhan BB, Sungur M, Celikel CA, Celikel T. Effect of inhaled cyclosporin on the rat airways: Histologic and bronchoalveolar lavage assessment. Respiration 1998; 65: 71-8.
17. Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur. Respir. J. 1997; 10: 292-300.
18. Synek M, Beasley R, Frew AJ et al. Cellular infiltration of the airways in asthma of varying severity. Am. J. Respir Crit. Care Med. 1996; 154: 224-30.
19. Haley KJ, Sunday ME, Wiggs BR et al. Inflammatory cell distribution within and along asthmatic airways. Am. J. Respir. Crit. Care Med. 1998; 158: 565-72.
20. Gonzalo JA, Lloyd CM, Kremer L et al. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J. Clin. Invest. 1996; 98: 2332-45.
21. Wolyniec WW, DeSanctis GT, Nabozny G et al. Reduction of antigen-induced airway hyperreactivity and eosinophilia in ICAM-deficient mice. Am. J. Respir. Cell. Mol. Biol. 1998; 18: 777-85.
22. Fukuda T, Fukushima Y, Numao T et al. Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am. J. Respir. Cell. Mol. Biol. 1996; 14: 84-94.
23. Hirata N, Kohrogi H, Iwagoe H et al. Allergen exposure induces the expression of endothelial adhesion molecules in passively sensitized human bronchus: Time course and the role of cytokines. Am. J. Respir. Cell. Mol. Biol. 1998; 18: 12-20.
24. Striz I, Mio T, Adachi Y et al. IL-4 induces ICAM-1 expression in human bronchial epithelial cells and potentiates TNF-α. Am. J. Physiol. 1999; 277: L58-64.
25. Mulligan MS, Vaporciyan AA, Miyasaki M, Tamayani T, Ward PA. Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am. J. Pathol. 1993; 142: 1739-49.
26. Ito A, Miyake M, Morishita M, Ito K, Torii S, Sakamoto T. Dexamethasone reduces lung eosinophilia, and VCAM-1 and ICAM-1 expression induced by Sephadex beads in rats. Eur. J. Pharmacol. 2003; 468: 59-66.
27. Evans CM, Jacoby DB, Fryer AD. Effects of dexamethasone on antigen-induced airway eosinophilia and M2 receptor dysfunction. Am. J. Respir. Crit. Care Med. 2001; 163: 1484-92.